argenx SE Files October 2024 6-K Report
Ticker: ARGX · Form: 6-K · Filed: Oct 31, 2024 · CIK: 1697862
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
argenx SE dropped its October 6-K, confirming it's a foreign private issuer filing 20-F.
AI Summary
On October 31, 2024, argenx SE filed a Form 6-K, reporting on its activities for the month of October 2024. The filing is a report of a foreign private issuer and indicates that the company files annual reports under Form 20-F. The principal executive offices are located in Amsterdam, the Netherlands.
Why It Matters
This filing provides an update on argenx SE's ongoing reporting as a foreign private issuer, which is important for investors tracking the company's regulatory disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- argenx SE (company) — Registrant
- 001-38097 (company) — SEC File Number
- 20241031 (date) — Filing Date
- October 2024 (date) — Reporting Period
FAQ
What type of filing is argenx SE submitting?
argenx SE is submitting a Form 6-K, which is a Report of Foreign Private Issuer.
What is the filing date of this Form 6-K?
The filing date is October 31, 2024.
What is the principal executive office location for argenx SE?
The principal executive offices are located at Laarderhoogteweg 25, 1101 EB Amsterdam, the Netherlands.
Does argenx SE file annual reports under Form 20-F or 40-F?
argenx SE indicates it files annual reports under cover of Form 20-F.
What is the SEC file number for argenx SE?
The SEC file number for argenx SE is 001-38097.
Filing Stats: 306 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-10-31 08:15:39
Filing Documents
- a01coverpageforsecfilingq3.htm (6-K) — 19KB
- a02earningspressreleaseq32.htm (EX-99.1) — 125KB
- argx_3q2024financialandb.htm (EX-99.2) — 15KB
- argenx_logoxrgba.jpg (GRAPHIC) — 110KB
- argx_3q2024financialandb001.jpg (GRAPHIC) — 82KB
- argx_3q2024financialandb002.jpg (GRAPHIC) — 237KB
- argx_3q2024financialandb003.jpg (GRAPHIC) — 140KB
- argx_3q2024financialandb004.jpg (GRAPHIC) — 126KB
- argx_3q2024financialandb005.jpg (GRAPHIC) — 125KB
- argx_3q2024financialandb006.jpg (GRAPHIC) — 106KB
- argx_3q2024financialandb007.jpg (GRAPHIC) — 92KB
- argx_3q2024financialandb008.jpg (GRAPHIC) — 131KB
- argx_3q2024financialandb009.jpg (GRAPHIC) — 143KB
- argx_3q2024financialandb010.jpg (GRAPHIC) — 98KB
- argx_3q2024financialandb011.jpg (GRAPHIC) — 95KB
- argx_3q2024financialandb012.jpg (GRAPHIC) — 96KB
- argx_3q2024financialandb013.jpg (GRAPHIC) — 95KB
- argx_3q2024financialandb014.jpg (GRAPHIC) — 79KB
- 0001697862-24-000012.txt ( ) — 2568KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ARGENX SE Date October 31, 2024 By s Hemamalini (Malini) Moorthy Hemamalini (Malini) Moorthy General Counsel